Prevention and control of Taenia solium taeniasis/cysticercosis in Peru

Pathogens and Global Health

Volumn 106, Issue 5, 2012, Pages 312-318

  Gilman, Robert H ^a,b   Gonzalez, Armando E ^b,c   Llanos Zavalaga, Fernando ^a   Tsang, Victor C W ^d   Garcia, Hector H ^a,b,e  

^a Universidad Peruana Cayetano Heredia   (Peru)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^d GEORGIA STATE UNIVERSITY   (United States)

^e INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

Author keywords

Cysticercosis; Epilepsy; Neurocysticercosis; Peru; Taenia solium; Taeniasis

Indexed keywords

ALBENDAZOLE; FLUBENDAZOLE; NICLOSAMIDE; OXFENDAZOLE; PRAZIQUANTEL;

ANTIGEN DETECTION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYSTICERCOSIS; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; HEALTH PROGRAM; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; INFECTION CONTROL; MICROSCOPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OXFENDAZOLE; PERU; POLYMERASE CHAIN REACTION; QUALITY OF LIFE; SCHISTOSOMIASIS; SEIZURE; SENSITIVITY AND SPECIFICITY; SEROLOGY; SINGLE DRUG DOSE; TAENIA SOLIUM; TAENIASIS;

ANIMALS; COMMUNICABLE DISEASE CONTROL; HUMANS; PERU; SWINE; TAENIA SOLIUM; TAENIASIS; ZOONOSES;

EID: 84874851197     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1179/2047773212Y.0000000045     Document Type: Article

References (75)

1. Garcia HH, Del Brutto OH. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 2005;4(10):653-661.
2. Schantz PM, Cruz M, Sarti E, Pawlowski Z. Potential eradicability of taeniasis and cysticercosis. Bull Pan Am Health Organ. 1993;27(4):397-403.
3. Gonzalez AE, Garcia HH, Gilman RH, Tsang VCW, The Cysticercosis Working Group in Peru. Control of Taenia solium. Acta Tropica. 2003;87:103-109.
4. Flisser A. Taeniasis and cysticercosis due to Taenia solium. Prog Clin Parasitol. 1994;4:77-116.
5. Lescano AG, Garcia HH, Gilman RH, Gavidia CM, Tsang VC, Rodriguez S, et al. Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS neglected tropical diseases. 2009;3(1):e371.
6. Lescano AG, Garcia HH, Gilman RH, Guezala MC, Tsang VC, Gavidia CM, et al. Swine cysticercosis hotspots surrounding Taenia solium tapeworm carriers. Am J Trop Med Hyg. 2007;76(2):376-383.
7. Budke CM, White AC, Garcia HH. Zoonotic larval cestode infections: neglected, neglected tropical diseases? PLoS neglected tropical diseases. 2009;3(2):e319.
8. Allan JC, Avila G, Garcia Noval J, Flisser A, Craig PS. Immunodiagnosis of taeniasis by coproantigen detection. Parasitology. 1990;101 Pt 3:473-477.
9. Garcia HH, Del Brutto OH. Taenia solium cysticercosis. Infect Dis Clin North Am. 2000;14(1):97-119.
10. Allan JC, Wilkins PP, Tsang VC, Craig PS. Immunodiagnostic tools for taeniasis. Acta Trop. 2003;87(1):87-93.
11. Guezala MC, Rodriguez S, Zamora H, Garcia HH, Gonzalez AE, Tembo A, et al. Development of a species-specific coproantigen ELISA for human Taenia solium taeniasis. Am J Trop Med Hyg. 2009;81(3):433-437.
12. Mayta H, Gilman RH, Prendergast E, Castillo JP, Tinoco YO, Garcia HH, et al. Nested PCR for specific diagnosis of Taenia solium taeniasis. J Clin Microbiol. 2008;46(1):286-289.
13. Gonzalez LM, Montero E, Sciutto E, Harrison LJ, Parkhouse RM, Garate T. Differential diagnosis of Taenia saginata and Taenia solium infections: from DNA probes to polymerase chain reaction. Trans R Soc Trop Med Hyg. 2002;96 Suppl 1: S243-S250.
14. Wilkins PP, Allan JC, Verastegui M, Acosta M, Eason AG, Garcia HH, et al. Development of a serologic assay to detect Taenia solium taeniasis. Am J Trop Med Hyg. 1999;60(2):199-204.
15. Levine MZ, Calderon JC, Wilkins PP, Lane WS, Asara JM, Hancock K, et al. Characterization, cloning, and expression of two diagnostic antigens for Taenia solium tapeworm infection. J Parasitol. 2004;90(3):631-638.
16. Gonzalez AE, Cama V, Gilman RH, Tsang VC, Pilcher JB, Chavera A, et al. Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg. 1990;43(2):194-199.
17. Handali S, Gonzalez AE, Hancock K, Garcia HH, Roberts JM, Gilman RH, et al. Porcine antibody responses to Taenia solium antigens rGp50 and sTs18var1. Am J Trop Med Hyg. 2004;71(3):322-326.
18. Garcia HH, Gilman RH, Gonzalez AE, Verastegui M, Rodriguez S, Gavidia C, et al. Hyperendemic human and porcine Taenia solium infection in Peru. Am J Trop Med Hyg. 2003;68(3):268-275.
19. Dorny P, Brandt J, Geerts S. Immunodiagnostic approaches for detecting Taenia solium. Trends Parasitol. 2004;20(6):259-260; author reply 60-61.
20. Nash TE, Garcia HH. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol. 2011;7(10):584-594.
21. Garcia HH, Del Brutto OH. Imaging findings in neurocysticercosis. Acta Tropica. 2003;87:71-78.
22. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoe- lectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis. 1989;159(1):50-59.
23. Deckers N, Dorny P. Immunodiagnosis of Taenia solium taeniosis/cysticercosis. Trends Parasitol. 2010;26(3):137-144.
24. Handali S, Klarman M, Gaspard AN, Noh J, Lee YM, Rodriguez S, et al. Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticer- cosis and taeniasis. Clin Vaccine Immunol. 2010;17(1):68-72.
25. Harrison LJ, Joshua GW, Wright SH, Parkhouse RM. Specific detection of circulating surface/secreted glycoproteins of viable cysticerci in Taenia saginata cysticercosis. Parasite Immunol. 1989;11(4):351-370.
26. Brandt JR, Geerts S, De Deken R, Kumar V, Ceulemans F, Brijs L, et al. A monoclonal antibody-based ELISA for the detection of circulating excretory-secretory antigens in Taenia saginata cysticercosis. International journal for parasitology. 1992;22(4):471-477.
27. Garcia HH. Serological diagnosis and follow-up of severe neurocysticercosis using HP10 antigen detection. Nat Clin Pract Neurol. 2007;3(9):488-489.
28. Medina MT, Duron RM, Martinez L, Osorio JR, Estrada AL, Zuniga C, et al. Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salama Study. Epilepsia. 2005;46(1):124-131.
29. Montano SM, Villaran MV, Ylquimiche L, Figueroa JJ, Rodriguez S, Bautista CT, et al. Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology. 2005;65(2):229-233.
30. Del Brutto OH, Santibanez R, Idrovo L, Rodriguez S, Diaz-Calderon E, Navas C, et al. Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia. 2005;46(4):583-587.
31. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, et al. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS neglected tropical diseases. 2010;4(11):e870.
32. Flisser A, Madrazo I, Plancarte A, Schantz P, Allan J, Craig P, et al. Neurological symptoms in occult neurocysticercosis after single taeniacidal dose of praziquantel. Lancet. 1993; 342(8873):748.
33. Torres JR. Use of praziquantel in populations at risk of neurocysticercosis. Rev Inst Med Trop Sao Paulo. 1989;31(4):290.
34. Johnson RB. Potential hazard of mass praziquantel use. Am J Med. 1986;80(6):A88.
35. Bustos JA, Rodriguez S, Jimenez JA, Moyano LM, Castillo Y, Ayvar V, et al. Detection of Taenia solium taeniasis coproantigen is an early indicator of treatment failure for taeniasis. Clin Vaccine Immunol. 2012;19(4):570-573.
36. Gonzalez AE, Garcia HH, Gilman RH, Gavidia CM, Tsang VC, Bernal T, et al. Effective, single-dose treatment or porcine cysticercosis with oxfendazole. Am J Trop Med Hyg. 1996;54(4):391-394.
37. Gonzalez AE, Falcon N, Gavidia C, Garcia HH, Tsang VC, Bernal T, et al. Treatment of porcine cysticercosis with oxfendazole: a dose-response trial. Vet Rec. 1997;141(16):420-422.
38. Sikasunge CS, Johansen MV, Willingham AL 3rd, Leifsson PS, Phiri IK. Taenia solium porcine cysticercosis: viability of cysticerci and persistency of antibodies and cysticercal antigens after treatment with oxfendazole. Veterinary parasitology. 2008;158(1-2):57-66.
39. Pondja A, Neves L, Mlangwa J, Afonso S, Fafetine J, Willingham AL 3rd, et al. Use of oxfendazole to control porcine cysticercosis in a high-endemic area of Mozambique. PLoS neglected tropical diseases. 2012;6(5):e1651.
40. Gonzalez AE, Falcon N, Gavidia C, Garcia HH, Tsang VC, Bernal T, et al. Time-response curve of oxfendazole in the treatment of swine cysticercosis. Am J Trop Med Hyg. 1998;59(5):832-836.
41. Tellez-Giron E, Ramos MC, Montante M. Effect of flubendazole on Cysticercus cellulosae in pigs. Am J Trop Med Hyg. 1981;30(1):135-138.
42. Gonzalez AE, Garcia HH, Gilman RH, Lopez MT, Gavidia C, McDonald J, et al. Treatment of porcine cysticercosis with albendazole. Am J Trop Med Hyg. 1995;53(5):571-574.
43. Flisser A, Gonzalez D, Plancarte A, Ostrosky P, Montero R, Stephano A, et al. Praziquantel treatment of brain and muscle porcine Taenia solium cysticercosis. 2. Immunological and cytogenetic studies. Parasitol Res. 1990;76(7):640-642.
44. Gonzalez AE, Bustos JA, Jimenez JA, Rodriguez ML, Ramirez MG, Gilman RH, et al. Efficacy of diverse antiparasitic treatments for cysticercosis in the pig model. Am J Trop Med Hyg. 2012;87(2):292-296.
45. The Cysticercosis Working Group in Peru. The marketing of cysticercotic pigs in the Sierra of Peru. Bull World Health Organ. 1993;71(2):223-228.
46. Praet N, Kanobana K, Kabwe C, Maketa V, Lukanu P, Lutumba P, et al. Taenia solium cysticercosis in the Democratic Republic of Congo: how does pork trade affect the transmission of the parasite? PLoS neglected tropical diseases. 2010;4(9).
47. Garcia HH, Gonzalez AE, Del Brutto OH, Tsang VC, Llanos- Zavalaga F, Gonzalvez G, et al. Strategies for the elimination of taeniasis/cysticercosis. J Neurol Sci. 2007;262(1-2):153-157.
48. Cruz M, Davis A, Dixon H, Pawlowski ZS, Proano J. Operational studies on the control of Taenia solium taeniasis/ cysticercosis in Ecuador. Bull World Health Organ. 1989;67(4):401-407.
49. Sarti E, Schantz PM, Avila G, Ambrosio J, Medina-Santillan R, Flisser A. Mass treatment against human taeniasis for the control of cysticercosis: a population-based intervention study. Trans R Soc Trop Med Hyg. 2000;94(1):85-89.
50. Keilbach NM, de Aluja AS, Sarti-Gutierrez E. A programme to control taeniasiscysticercosis (T. solium): experiences in a Mexican village. Acta Leiden. 1989;57(2):181-189.
51. Allan JC, Velasquez-Tohom M, Fletes C, Torres-Alvarez R, Lopez-Virula G, Yurrita P, et al. Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs. Trans R Soc Trop Med Hyg. 1997;91(5):595-598.
52. Garcia HH, Gonzalez AE, Gilman RH, Moulton LH, Verastegui M, Rodriguez S, et al. Combined human and porcine mass chemotherapy for the control of T. solium. Am J Trop Med Hyg. 2006;74(5):850-855.
53. Kyvsgaard NC, Johansen MV, Carabin H. Simulating transmission and control of Taenia solium infections using a Reed- Frost stochastic model. Int J Parasitol. 2007;37(5):547-558.
54. Sarti E, Flisser A, Schantz PM, Gleizer M, Loya M, Plancarte A, et al. Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico. Am J Trop Med Hyg. 1997;56(2):127-132.
55. Verster A, Du Plessis TA, van Den Heever LW. The effect of gamma radiation on the cysticerci of Taenia solium. Onderstepoort J Vet Res. 1976;43(1):23-26.
56. Sotelo J, Rosas N, Palencia G. Freezing of infested pork muscle kills cysticerci. JAMA. 1986;256(7):893-894.
57. Molinari JL, Rodriguez D, Tato P, Soto R, Arechavaleta F, Solano S. Field trial for reducing porcine Taenia solium cysticercosis in Mexico by systematic vaccination of pigs. Vet Parasitol. 1997;69(1-2):55-63.
58. Molinari JL, Soto R, Tato P, Rodriguez D, Retana A, Sepulveda J, et al. Immunization against porcine cysticercosis in an endemic area in Mexico: a field and laboratory study. Am J Trop Med Hyg. 1993;49(4):502-512.
59. de Aluja AS, Villalobos NM, Nava G, Toledo A, Martinez JJ, Plancarte A, et al. Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs. Vaccine. 2005;23(31):4062-4069.
60. Gonzalez AE, Gilman RH, Garcia HH, Lopez T. Use of a simulation model to evaluate control programmes against Taenia solium cysticercosis. In: Singh G, Prabhakar S, editors. Taenia solium cysticercosis: from basic to clinical science. Oxon: CABI Publishing; 2002. p. 437-48.
61. Gonzalez AE. Evaluation of a control programme for Taenia solium targeting human and porcine health. Reading: University of Reading; 1997.
62. Flisser A, Gauci CG, Zoli A, Martinez-Ocana J, Garza- Rodriguez A, Dominguez-Alpizar JL, et al. Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect Immun. 2004; 72(9):5292-5297.
63. Gonzalez AE, Gauci CG, Barber D, Gilman RH, Tsang VC, Garcia HH, et al. Vaccination of pigs to control human neurocysticercosis. Am J Trop Med Hyg. 2005;72(6):837-839.
64. Assana E, Kyngdon CT, Gauci CG, Geerts S, Dorny P, de Deken R, et al. Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol. 2010;40(5):515-519.
65. Lightowlers MW. Eradication of Taenia solium cysticercosis: a role for vaccination of pigs. Int J Parasitol. 2010;40(10):1183-1192.
66. Jayashi CM, Kyngdon CT, Gauci CG, Gonzalez AE, Lightowlers MW. Successful immunization of naturally reared pigs against porcine cysticercosis with a recombinant onco- sphere antigen vaccine. Vet Parasitol. 2012;188(3-4):261-267.
67. Prichard RK, Basanez MG, Boatin BA, McCarthy JS, Garcia HH, Yang GJ, et al. A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis. 2012;6(4):e1549.
68. Huerta M, de Aluja AS, Fragoso G, Toledo A, Villalobos N, Hernandez M, et al. Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico. Vaccine. 2001;20(1-2):262-266.
69. Guo A, Jin Z, Zheng Y, Hai G, Yuan G, Li H, et al. Induction of protection against porcine cysticercosis in growing pigs by DNA vaccination. Vaccine. 2007;25(1):170-175.
70. Murrell KD. WHO/FAO/OIE Guidelines for the surveillance, prevention and control of taeniasis/cysticercosis. Paris: OIE; 2005.
71. World Health Organization. Report of the WHO Expert Consultation on Foodborne Trematode Infections and Taeniasis/Cysticercosis. Geneve: WHO; 2011.
72. O'Neal S, Winthrop K, Gonzalez AE. Cysticercosis control: bringing advances to the field. J Glob Infect Dis. 2011;3:156-160.
73. Ito A, Okamoto M, Li T, Wandra T, Dharmawan NS, Swastika KI, et al. The first workshop towards the control of cestode zoonoses in Asia and Africa. ParasitVectors. 2011;4:114.
74. Willingham AL, Wu HW, Conlan J, Satrija F. Combating Taenia solium cysticercosis in Southeast Asia an opportunity for improving human health and livestock production. Adv Parasitol. 2010;72:235-266.
75. Molyneux D, Hallaj Z, Keusch GT, McManus DP, Ngowi H, Cleaveland S, et al. Zoonoses and marginalised infectious diseases of poverty: where do we stand? Parasit Vectors. 2011;4:106.